Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
November 26, 2007

OncoMethylome Sciences Inks Biomarker Development Deal with GSK

  • OncoMethylome Sciences and GlaxoSmithKline Biologicals will collaborate to develop DNA methylation biomarkers for use in the personalization of cancer treatment with certain immunotherapeutics in development by GSK Biologicals.

    "We look forward to using our high-throughput platform to efficiently test our portfolio of methylation biomarkers on clinical samples provided by GSK Biologicals," commented Jim DiGuiseppi, CTO of OncoMethylome. 

Related content

  • You’re all set! Thank you for subscribing to GEN Highlights.